Singapore: Rapid growth in microRNA (miRNA) research over the past two years, which is fuelled by its diagnostic and the...
Singapore: VolitionRx, focused on developing blood-based diagnostic tests for a broad range of cancer types and other co...
Singapore: Japan's firm, Otsuka Pharmaceutical, has established a direct presence in Sydney, Australia, to bring innovat...
Singapore: The global prophylactic human papillomavirus (HPV) vaccine market value is forecast to experience moderate gr...
Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2....
Singapore: Novartis' novel antimalarial drug, KAE609 (cipargamin) has shown efficacy in Phase 2 trial by demonstrating t...
Singapore: Boehringer Ingelheim has acquired investigational drug PXS4728A from Australia based Pharmaxis, to develop it...
Singapore: Australia based, Circadian Technologies, through its wholly owned subsidiary Opthea has recieved USFDA approv...
Singapore: Glioblastoma multiforme (GBM) therapeutics market in Asia-Pacific (APAC) is estimated to grow double from USD...
The US scientists have created a promising second-generation antibiotic to fight against the bacteria that commonly caus...
Singapore: Valacyclovir, a drug indicated to control the virus that causes genital herpes, appears to reduce the levels ...
Singapore: The US Food and Drug Administration (FDA) has approved US-based ViiV Healthcare's single dose Triumeq tablet...
Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designe...
Singapore: Abivax, a leading clinical stage biotech company developing and commercializing anti-viral compounds and huma...
Singapore: Japan-based Eisai recieved US FDA approval for the US supply of the epilepsy drug Fycompa (perampanel) from i...
Singapore: Johnson & Johnson (J&J) is contemplating the thought of treating depression using popular street drug...
Singapore: Impax laboratories in Taiwan recently announced that FDA had delayed its decision on Rytary, the first non-ge...
Singapore: Hironic, based out of Seoul, Korea, is an innovator of medical aesthetic laser and energy devices. The compan...
